Literature DB >> 1380641

B-cell epitopes of La and Ro autoantigens.

S Whittingham1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1380641     DOI： 10.1007/BF00464705

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN： 0301-4851            Impact factor:   2.316


× No keyword cloud information.
  85 in total

1.  Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses.

Authors:  J D Reveille; M J Macleod; K Whittington; F C Arnett
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

Review 2.  Ro (SS-A) and La (SS-B) ribonucleoprotein complexes: structure, function and antigenicity.

Authors:  R L Slobbe; G J Pruijn; W J Van Venrooij
Journal:  Ann Med Interne (Paris)       Date:  1991

3.  Ro/SS-A antigen in human platelets. Different distributions of the isoforms of Ro/SS-A protein and the Ro/SS-A-binding RNA.

Authors:  Y Itoh; M Reichlin
Journal:  Arthritis Rheum       Date:  1991-07

4.  A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein.

Authors:  R H Scofield; W D Dickey; K W Jackson; J A James; J B Harley
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

5.  The small nuclear ribonucleoprotein SS-B/La binds RNA with a conserved protease-resistant domain of 28 kilodaltons.

Authors:  E K Chan; E M Tan
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome.

Authors:  R I Fox; G Pearson; J H Vaughan
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

7.  The Ro ribonucleoprotein particle: induction of autoantibodies and the detection of Ro RNAs among species.

Authors:  M J Mamula; C A O'Brien; J B Harley; J A Hardin
Journal:  Clin Immunol Immunopathol       Date:  1989-09

8.  Intracellular distribution of the La antigen in CV-1 cells after herpes simplex virus type 1 infection compared with the localization of U small nuclear ribonucleoprotein particles.

Authors:  M Bachmann; D Falke; H C Schröder; W E Müller
Journal:  J Gen Virol       Date:  1989-04       Impact factor: 3.891

9.  Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide.

Authors:  T S Lieu; M M Newkirk; J D Capra; R D Sontheimer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Detection of Epstein-Barr virus antigens and DNA in major and minor salivary glands using immunocytochemistry and polymerase chain reaction: possible relationship with Sjogren's syndrome.

Authors:  E M Deacon; J B Matthews; A J Potts; J Hamburger; I S Bevan; L S Young
Journal:  J Pathol       Date:  1991-04       Impact factor: 7.996
View more
  4 in total

1.  Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein.

Authors:  G Boire; M Gendron; N Monast; B Bastin; H A Ménard
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

2.  Localization of autoepitopes on the PCM-1 autoantigen using scleroderma sera with autoantibodies against the centrosome.

Authors:  L Bao; C E Varden; W E Zimmer; R Balczon
Journal:  Mol Biol Rep       Date:  1998-03       Impact factor: 2.316

3.  Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.

Authors:  E V Staikou; J G Routsias; A A Makri; A Terzoglou; M Sakarellos-Daitsiotis; C Sakarellos; G Panayotou; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

4.  Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.

Authors:  V Ricchiuti; J P Briand; O Meyer; D A Isenberg; G Pruijn; S Muller
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.